Role of laminin in ovarian cancer turner growth and metastasis via regulation of Mdm2 and Bcl-2 expression

被引:0
|
作者
Yoshida, Y
Hosokawa, K
Dantes, A
Kotsuji, F
Kleinman, HK
Amsterdam, A [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
[2] Fukui Med Univ, Dept Obstet & Gynecol, Fukui 9101193, Japan
[3] NIDCR, Cell Biol Sect, NIH, Bethesda, MD 20892 USA
关键词
laminin; laminin peptides; ovarian cancer; Mdm2; Bcl-2;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian cancer is among the most lethal cancers in women because of its high metastatic potential and lack of response to therapy. An experimental model to study this disease was developed using a transformed granulosa cell line expressing a mutant p53 and Ha-ras. When injected into the ovary of nude mice in the presence of laminin-l, tumors develop in the ovary and peritoneum and metastasize to various organs, leading to death within 21 days. In contrast, when cells were injected in the presence of gelatin, development of tumors was slower and no metastases were observed by day 21. Here we investigated the possible mechanism by which laminin-l exerts its promotion of tumorigenesis and metastasis. Cells were co-injected with laminin-l and active laminin peptides from the al; (A13: RQVFQVAYIIIKA, A12: WVTVTLDL RQVFQ, AG73: LQVQLSIR, IKVAV) and beta1 (YIGSR) chains. Ovarian tumor growth and metastasis were increased in the presence of laminin-l plus either AG73 peptide, IKVAV, or A13, and were significantly reduced in the presence of A12 or YIGSR. Expression of Bcl-2 and Mdm2 was higher by 3.5- and about 100-fold, respectively, in ovarian tumors grown in the presence of laminin compared to tumors grown in the presence of gelatin. Moreover, peptides A13 and AG73 further elevated Bcl-2 expression by 6- and 7-fold respectively, while IKVAV yielded expression similar to laminin-l. YIGSR and A12 reduced the expression of Bcl-2 by 7- and 3-fold, respectively, compared to treatment with laminin-l. A13 and AG73 increased Mdm2 expression by 1.8- and 1.3-fold, respectively, while IKVAV, A12, and YIGSR were without effect. Thus, laminin-l exerts its proliferative effect on the development of ovarian tumors via upregulation of survival genes such as Bcl-2 and Mdm2. Peptides A13 and AG73 (which increased tumor growth and spread) enhance the expression of these genes and A12 and YIGSR (which decrease tumor growth and spread) attenuate their expression. IKVAV probably enhances tumor growth and metastasis by another mechanism.
引用
收藏
页码:913 / 921
页数:9
相关论文
共 50 条
  • [1] Expression of heparanase, Mdm2, and erbB2 in ovarian cancer
    Ginath, S
    Menczer, J
    Friedmann, Y
    Aingorn, H
    Aviv, A
    Tajima, K
    Dantes, A
    Glezerman, M
    Vlodavsky, I
    Amsterdam, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (06) : 1133 - 1144
  • [2] Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer
    Baekelandt, M
    Kristensen, GB
    Nesland, JM
    Tropé, CG
    Holm, R
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2061 - 2068
  • [3] MDM2 Expression and Regulation in Prostate Cancer Racial Disparity
    Wang, Guimin
    Firoz, Elnaz F.
    Rose, Amy
    Blochin, Elen
    Christos, Paul
    Pollens, Danuta
    Mazumdar, Madhu
    Gerald, William
    Oddoux, Carole
    Lee, Peng
    Osman, Iman
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2009, 2 (04): : 353 - 360
  • [4] bcl-2, p53 and mdm2 protein expression in gastritis, dysplasia and gastric adenocarcinoma
    Konstantinos, T
    Tzouvala, M
    Kapranos, N
    Papatheodoridis, GV
    Zizi, A
    Milonaki, M
    Elemenoglou, J
    Karamanolis, DG
    GASTROENTEROLOGY, 1999, 116 (04) : A442 - A442
  • [5] A novel MDM2 inhibitor suppresses breast cancer growth and metastasis
    Qin, Jiang-Jiang
    Wang, Wei
    Voruganti, Sukesh
    Zhang, Ruiwen
    CANCER RESEARCH, 2015, 75
  • [6] MDM2 and BCL-2: to p53 or not to p53?
    Wang, Eunice S.
    BLOOD, 2023, 141 (11) : 1237 - 1238
  • [7] Mdm2 in growth signaling and cancer
    Levav-Cohen, Y
    Haupt, S
    Haupt, Y
    GROWTH FACTORS, 2005, 23 (03) : 183 - 192
  • [8] P15, MDM2, NF-κB, and Bcl-2 expression in primary bone tumor and correlation with tumor formation and metastasis
    Qian, Guibin
    Hao, Songnan
    Yang, Dawei
    Meng, Qinggang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 14885 - 14892
  • [9] Understanding and overcoming resistance of MDM2 and Bcl-2/Bcl-xL small-molecule inhibitors in human cancer
    Wang, Shaomeng
    Hoffman-Luca, Cassandra Gianna
    Bai, Longchuan
    Lu, Jianfeng
    McEachem, Donna
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [10] Clinical significance of p53, MDM2 and bcl-2 expression in transitional cell carcinoma of the bladder
    Uchida, T
    Minei, S
    Gao, JP
    Wang, CY
    Satoh, T
    Baba, S
    ONCOLOGY REPORTS, 2002, 9 (02) : 253 - 259